Bio-Rad Laboratories, Inc. Share Price
Equities
BIO
US0905722072
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
275.9 USD | +0.12% | -1.35% | -14.54% |
Sales 2024 * | 2.71B 226B | Sales 2025 * | 2.86B 238B | Capitalization | 7.89B 658B |
---|---|---|---|---|---|
Net income 2024 * | 444M 37.02B | Net income 2025 * | 509M 42.44B | EV / Sales 2024 * | 2.66 x |
Net cash position 2024 * | 661M 55.09B | Net cash position 2025 * | 1.24B 104B | EV / Sales 2025 * | 2.33 x |
P/E ratio 2024 * |
18.1
x | P/E ratio 2025 * |
15.8
x | Employees | 8,030 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66% |
Latest transcript on Bio-Rad Laboratories, Inc.
1 day | +0.12% | ||
1 week | -1.35% | ||
Current month | -20.22% | ||
1 month | -18.97% | ||
3 months | -16.14% | ||
6 months | -5.35% | ||
Current year | -14.54% |
Managers | Title | Age | Since |
---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 74 | 01/89/01 |
Gregory Hinckley
DFI | Director of Finance/CFO | 77 | 01/83/01 |
Andrew Last
COO | Chief Operating Officer | 64 | 22/19/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Edwards
BRD | Director/Board Member | 64 | 25/17/25 |
Alice Schwartz
FOU | Founder | 97 | 01/52/01 |
Gregory Hinckley
BRD | Director/Board Member | 77 | 25/17/25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.90% | 2 M€ | +6.77% | ||
1.01% | 16 M€ | -8.49% | ||
0.76% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 275.9 | +0.12% | 179,207 |
25/24/25 | 275.6 | -0.94% | 164,776 |
24/24/24 | 278.2 | -2.48% | 209,104 |
23/24/23 | 285.3 | +1.84% | 250,549 |
22/24/22 | 280.1 | +0.14% | 217,079 |
Delayed Quote Nyse, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.54% | 7.89B | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.36% | 26.25B | |
+2.07% | 26.48B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- BIO Stock